DOI QR코드

DOI QR Code

Assessment of Biochemical Profiles in Premenopausal and Postmenopausal Women with Breast Cancer

  • Yadav, Naval Kishor (Department of Biochemistry, College of Medical Sciences) ;
  • Poudel, Bibek (Department of Biochemistry, College of Medical Sciences) ;
  • Thanpari, C. (Department of Biochemistry, College of Medical Sciences) ;
  • Koner, Bidhan Chandra (Department of Biochemistry, College of Medical Sciences)
  • 발행 : 2012.07.31

초록

Objective: The study was conducted to assess biochemical profiles in premenopausal and postmenopausal women having breast cancer. Materials and Methods: A hospital based case control study was carried out at Manipal Teaching Hospital (MTH), Pokhara, Nepal. The analysed variables were age, metabolic profile including total cholesterol, triglycerides, HDL-C, LDL-C, blood sugar, insulin concentration, C-peptide, HbA1c and selenium. Descriptive statistics and testing of hypothesis were used for the analysis using EPI INFO and SPSS 16 software. Results: In premenopausal women, significant differences were noted for total cholesterol (P value <0.001), triglycerides (P value 0.002), HbA1c level (P value <0.001), insulin concentration (P value 0.030), C-peptide concentration (P value 0.001), and selenium (P value <0.001) between cases and controls. Insignificant results were found for HDL-C (P value 0.749), LDL-C (P value 0.933), blood sugar (P value 0.59) and BMI (P value 0.746). Similarly, significant difference in total cholesterol (P value <0.001), triglycerides (P value 0.001), LDL-C (P value <0.001), HDL-C (P value 0.025), blood sugar (P value <0.001), insulin concentration (P value <0.001), c-peptide concentration (P value <0.001), HbA1c level (P value <0.001) and selenium (P value <0.001) were observed for postmenopausal patients and controls. Conclusions: Assessing metabolic changes and their management may be important for control of breast cancer and increased survival.

키워드

참고문헌

  1. Abu-Bedair FA, El-Gamal BA, Ibrahim NA, et al (2003). Serum lipids and tissue DNA content in Egyptian female breast cancer patients. Jpn J Clin Oncol, 33, 278-82. https://doi.org/10.1093/jjco/hyg059
  2. Banu S, Adem V, Sakine C, et al (2003). Association between oxidative stress and selenium levels in patients with breast cancer at different clinical stages. J Trace Elements in Experimental Medicine, 16, 87-94. https://doi.org/10.1002/jtra.10030
  3. Benson JR, Jatoi I, Keisch M, et al (2009). Early breast cancer. Lancet, 373, 1463-79. https://doi.org/10.1016/S0140-6736(09)60316-0
  4. Brandt A, Bermejo JL, Sundquist J, et al (2010). Age of onset in familial breast cancer as background data for medical surveillance. Br J Cancer, 102, 42-7. https://doi.org/10.1038/sj.bjc.6605421
  5. Charalabopoulos K, Kotsalos A, Batistatou A, et al (2006). Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA. Br J Can, 95, 674-6. https://doi.org/10.1038/sj.bjc.6603292
  6. Chow LW, Cheng CW, Wong JL, et al (2005). Serum lipid profiles in patients receiving endocrine treatment for breast cancer--the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial. Biomed Pharmacother, 59, 302-5. https://doi.org/10.1016/j.biopha.2005.05.003
  7. Conlon MS, Johnson KC, Bewick MA, et al (2010). Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer. Cancer Epidemiol, 34, 142-9. https://doi.org/10.1016/j.canep.2010.02.001
  8. Cuzick J (2010). Breast cancer prevention in the developing World. Breast Cancer Res, 12, 9.
  9. Datta K, Choudhuri M, Guha S, et al (2012). Breast Cancer Scenario in a Regional Cancer Centre in Eastern India over Eight Years - Still a Major Public Health Problem. Asian Pac J Cancer Prev, 13, 809-13. https://doi.org/10.7314/APJCP.2012.13.3.809
  10. Frier BM, Ashby JP, Nairn IM, et al (1981). Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide. Diab Metab, 7, 45-9.
  11. Furberg AS, Veierod MB, Wilsgaard T, et al (2004). Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst, 96, 1152-60. https://doi.org/10.1093/jnci/djh216
  12. Garland M, Morris JS, Stampfer MJ, et al (1995). Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst, 87, 497-505. https://doi.org/10.1093/jnci/87.7.497
  13. Gooden PJ, Boyd NF, Hanna W, et al (1997). Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer, 27, 284-92. https://doi.org/10.1080/01635589709514539
  14. Hadjisawas A, Loizidou MA, Middleton N, et al (2010). An investigation of breast cancer risk factors in Cyprus: a case control study. BMC Cancer, 10, 447. https://doi.org/10.1186/1471-2407-10-447
  15. Hortobagyi GN, De La Garza Salazar J, Pritchard K, et al (2005). The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer, 6, 391-401. https://doi.org/10.3816/CBC.2005.n.043
  16. Horwitz DL, Kuzuya L, Rubenstein AR (1976). Circulating serum C- peptide: A brief review of diagnostic implications. N Eng J Med, 295, 207-18. https://doi.org/10.1056/NEJM197607222950407
  17. Hoyer AP, Engholm G (1992). Serum lipids and breast cancer risk: a cohort study of 5, 207 Danish women. Cancer Causes Control, 3, 403-8. https://doi.org/10.1007/BF00051352
  18. Irwin ML, Duggan C, Wang CY, et al (2011). Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol, 29, 47-53. https://doi.org/10.1200/JCO.2010.28.4752
  19. Jasim BT (2011). Determination the Erythrocyte glutathione peroxidase activity and Serum selenium level in patients with breast cancer. Tikrit J Pure Sci, 16, 4-8.
  20. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  21. Kokoglu E, Karaarslan I, Karaarslan HM, et al (1994). Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett, 82, 175-8. https://doi.org/10.1016/0304-3835(94)90008-6
  22. Kuru B, Ozaslan C, Ozdemir P, et al (2002). Risk factors for breast cancer in Turkish women with early pregnancies and long-lasting lactation. Acta Oncol, 6, 556-61.
  23. Liao S, Li J, Wang L, et al (2010). Type 2 Diabetes Mellitus and Characteristics of Breast Cancer in China. Asian Pac J Cancer Prev, 11, 933-7.
  24. Lopez-Saez JB, Martinez-Rubio JA, Alvarez MM, et al (2008). Metabolic profile of breast cancer in a population of women in southern Spain. Open Clin Cancer J, 18, 1-6.
  25. Mahabir S, Baer DJ, Johnson LL, et al (2006). Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women. Cancer Epidemiol Biomarkers Prev, 15, 2502-7. https://doi.org/10.1158/1055-9965.EPI-06-0499
  26. Mannisto S, Alfathan G, Virtanen M, et al (2000). Toenail selenium and breast cancer a case-control study in Finland. Eur J Clin Nutr, 54, 98-103. https://doi.org/10.1038/sj.ejcn.1600902
  27. McPherson K, Steel CM, Dixon JM (2000). Breast cancer-epidemiology, risk factors, and genetics. BMJ, 321, 624-8. https://doi.org/10.1136/bmj.321.7261.624
  28. Owiredu WK, Donkor S, Addai BM, et al (2009). Serum lipid profile of breast cancer patients. Pak J Biol Sci, 12, 332-8. https://doi.org/10.3923/pjbs.2009.332.338
  29. Qi XY, Zhang AY, Wu GL, et al (1994). The association between breast cancer and diet and other factors. Asia Pac J Public Health, 7, 98-104. https://doi.org/10.1177/101053959400700204
  30. Ray G, Husain SA (2001). Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem, 34, 71-6. https://doi.org/10.1016/S0009-9120(00)00200-9
  31. Schootman M, Jeffe D, Lian M, et al (2009). The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: a geographic and multilevel analysis. Am J Epidemiol, 169, 554-61.
  32. Sezer H, Yilmaz M, Gurler H, et al (2011). Breast cancer risk factors in Turkey: a hospital-based case-control study. Asian Pac J Cancer Prev, 12, 2317-22.
  33. Singh YP, Sayami P (2009). Management of breast cancer in Nepal. J Nepal Med Association, 48, 252-7.
  34. Takatani O, Okumoto T, Kosano H (1991). Genesis of breast cancer in Japanese: a possible relationship between sex hormone-binding globulin (SHBG) and serum lipid components. Breast Cancer Res Treat, 18, 527-9.
  35. Vona-Davis L, Rose DP (2009). The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health, 18, 883-93. https://doi.org/10.1089/jwh.2008.1127
  36. Zielinski CC, Stuller I, Rausch P, et al (1988). Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer. J Can Res Clin Oncol, 114, 514-8. https://doi.org/10.1007/BF00391503

피인용 문헌

  1. The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review vol.44, pp.1, 2013, https://doi.org/10.1111/eci.12185
  2. Does cancer risk increase with HbA1c, independent of diabetes? vol.110, pp.9, 2014, https://doi.org/10.1038/bjc.2014.150
  3. Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression vol.14, pp.1, 2014, https://doi.org/10.1186/1471-2407-14-132
  4. Preparation of Selenium-enriched Bifidobacterium Longum and its Effect on Tumor Growth and Immune Function of Tumor-Bearing Mice vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3681
  5. Could Low Hdl-Cholesterol Levels Be an Unvalued Predictor of Cancer Risk?: A Retrospective Case Study vol.06, pp.12, 2015, https://doi.org/10.4236/ijcm.2015.612129
  6. Clinically Relevant Physical Benefits of Exercise Interventions in Breast Cancer Survivors vol.18, pp.2, 2016, https://doi.org/10.1007/s11912-015-0496-3
  7. Efficacy of Complementary Therapies in the Quality of Life of Breast Cancer Survivors vol.7, pp.2234-943X, 2018, https://doi.org/10.3389/fonc.2017.00326